ACCESS Award supports clinical research teams testing low-cost, scalable cancer interventions to improve treatment and expand equitable access worldwide, particularly in low- and middle-income countries.
Advanced Clinical Research Award supports independent mid-career physicians pursuing original breast cancer clinical or human-subjects translational research to address patient needs and potential benefit.
Rising Tide/LUNGevity Award for Early Detection of Lung Cancer in LMICs supports researchers conducting validation studies and clinical trials to advance affordable, scalable early lung cancer detection in LMICs.
Equity in Access Research Grants support researchers studying insurance-related barriers to blood cancer care and actionable solutions to improve equitable access for patients and survivors.
Extramural Discovery Science Accelerator Award supports cancer researchers with experiments to validate and de-risk technologies from ongoing projects, helping move them toward commercialization.
Acceleration Initiative Award supports researchers pursuing translational and preclinical pediatric cancer treatment research to overcome development barriers and reach clinical trials within three years.